Can integrated multi-testing strengthen TB care and help detect more in one visit?
Public health experts are debating the feasibility of integrated multi-disease testing for conditions like TB, HIV, and hepatitis. While diagnostic platforms can technically identify multiple pathogens, experts warn that the primary challenge remains the requirement for different types of clinical specimens for each disease.
In 2017, the World Health Organization (WHO) issued an information note on multi-disease testing devices in integrated laboratory networks, saying such platforms could improve efficiency, reduce costs and increase patient access by allowing disease-specific tests for TB, HIV and viral hepatitis on a common platform. WHO has subsequently continued to support diagnostic integration.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in